Explore mushroom research and guides on psilocybin legal access.
The FDA clears more than 99% of expanded access requests. Yet no psilocybin compassionate use case has succeeded in the US. Here's the two-gate DEA barrier, the MDMA program that got through it, and how Canada solved it.
